Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Non-Current Deffered Revenue (2022)

60 Degrees Pharmaceuticals (SXTP) has disclosed Non-Current Deffered Revenue for 1 consecutive years, with $255000.0 as the latest value for Q4 2022.

  • On a quarterly basis, Non-Current Deffered Revenue changed N/A to $255000.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $255000.0, a N/A change, with the full-year FY2022 number at $255000.0, changed N/A from a year prior.
  • Non-Current Deffered Revenue was $255000.0 for Q4 2022 at 60 Degrees Pharmaceuticals.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $255000.0 in Q4 2022 to a low of $255000.0 in Q4 2022.